Τόμος 13 (1995) – Τεύχος 1 – Άρθρο 2 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 13 (1995) – Issue 1 – Article 2 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Κωνσταντίνος Λ. Παπαδόπουλος

Β΄ Καρδιολογική Κλινική Αριστετελείου Πανεπιστημίου, Ιπποκράτειο Γενικό Περιφερικό Νοσοκομείο Θεσσαλονίκης, Μακεδονία, Ελλάδα

C.L. Papadopoulos

2nd Department of Cardiology, Aristotle Univer­sity, Hippokration General Hospital, Thessaloniki, Macedonia, Greece

1. Moncada, S., Vane, J.R.: Pharmacology and en­dogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol. Rev. 30: 293 (1979)
2. Furchgott, R.F., Zawadski, J.V.: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylocholine. Nature 288: 373 (1980)
3. Radomski, W.M., Palmer, R.M.J., Moncada S: The antiaggregating properties of vascular endothe­lium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92: 639 (1987)
4. Radomski, M.S., Palmer, R.M.J., Moncada, S.: An L-arginine nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA 87: 5193 (1990)
5. Ofosu, F.A., Modi, G.J., Smith, L.M., Cerskus, A.L., Hirsh, J., Blajchman, M.A.: Heparan sulfate and dermatan sulfate inhibit the generation of thrombin in plasma by complementary pathways. Blood 64: 742 (1984)
6. Loskutoff, D.J., Edgington, T.S.: Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc. Natl. Acad. Sci. USA 74; 3903 (1977)
7. Rubanyi, G.M.: Vascular effects of oxygen-de­rived free radicals. Free Radic Biol. Med. 4: 107 (1988)
8. Rubanyi, G.M., Vanhoutte, P.M.: Superoxide ani­ons and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 250: H822 (1986)
9. Vanhoutte, P.M., Rubanyi, G.M., Miller, V.M., Houston, D.S.: Modulation of vascular smooth mus­cle contraction by the endothelium. Ann. Rev. Physiol. 48: 307 (1986)
10. G.M. Rubanyi (ed.): Cardiovascular Significance of Endothelium Derived Vasoactive Factors. Futura, Mount Kisco, New York, 1991
11. Thilo-Korner, D.G.S., Heinrich, D., Lasch, H.G.: Endothelial cell control functions in blood coagulation. In: The Endothelial Cell – A Plurispotent Control Cell of the Vessel Wall (D.G.S. Thilo-Korner, R.I. Freshey, eds), Karger, Basel, 1982
12. Berkenboom, G., Depierreux, M., Fontaine, J.: The influence of atherosclerosis on the mechanical responses of human isolated coronary arteries to substances P, isoprenaline and noradrenaline. Br. J. Pharmacol. 92: 113 (1987)
13. Vita, J.A., Treasure, C.B., Nabel, E.G., et al.: The coronary vasomotor response of acetylcholine related to risk factors for coronary artery disease. Circulation 81: 491 (1990)
14. Habenich, A.J.R., Glomset, J.A., King, W.C., et al.: Early changes in phosphatidylinositol and arachidonic acid metabolism in quiescent Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J. Biol. Chem.: 2329 (1981)
15. Rubanyi, G.M.: Endothelial-derived vasoconstric­tor factors. In: Endothelial Cells (U.S. Ryan, ed.), vol.II, CRC Press, Boca Raton, F.L., 1988
16. Katusic, Z.S., Shepherd, J.T., Vanhoutte, P.M.: Endothelium-dependent contraction to stretch in ca­nine basilar arteries. Am. J. Physiol. 252: H671 (1987)
17. Rubanyi, G.M., Freay, D.D., Johns, A., Van Breemen, C.: Elevated transmural pressure inhibits the release of EDRF by mechanism(s) similar to high K+and barium. In: Resistance Arteries, Structure and Function (M.J. Mulvany, ed.), Elsevier, New York, 1991
18. Mikhail, N., Fukuda, N., Tremblay, J., Hamet, P.: Platelets, growth factors and vascular smooth-mus­cle cells in hypertension and diabetes. J. Cardiovasc. Pharmacol. 22(Suppl 6): S64 1993
19. Rubany, G.M.: Reversal of hypercholesterolemia-induced endothelial dysfunction by L-arginine. Circu­lation 83: 1118 (1991)
20. Quinn, M.T., Pathasarathy, S., Fong, L.G., Stein­berg, D.: Oxidatively modified low density lipoprotein. Proc. Natl. Acad. Sci. USA 84: 2995 (1987)
21. Heistad, D., Armstrong, M., Marcus, M., et al.: Augmented responses to vasoconstrictor stimuli in hypercholerinemic and atherosclerotic monkeys. Circ. Res. 54: 711 (1984)
22. Duhm, J.: Possible role of plasma lipids in altera­tion of cell membrane sodium transport in essential hypertension: Pathogenetic implication. In: Blood Cells and Arteries in Hypertension and Atheroscle­rosis (P. Meyer, P. Marche, eds), p. 247, Raven Press, New York 1989
23. Πα­πα­δό­που­λος, Κ., Μισ­σο­πού­λου-Κόκ­κα, Α.: Λι­πο­πρω­τε­ϊ­νες. Επιθ. Κλιν. Φαρ­μα­κολ. Φαρ­μα­κο­κιν. 9: 5-14 (1991)
24. Πα­πα­δό­που­λος, Κ., Σα­κα­ντά­μης, Γ.: Πα­θο­γε­νε­τι­κές από­ψεις για τις καρ­διο­αγ­γει­α­κές επι­πλο­κές του σακ­χα­ρώ­δους δια­βή­του. Ια­τρ. Επιθ. Εν. Δυν. 21: 1-16 (1987)
25. Πα­πα­δό­που­λος, K.: Α­ντια­θη­ρω­μα­τι­κή δρά­ση α­ντα­γω­νι­στών α­σβε­στί­ου. Ελ­λ. Καρ­διολ. Ε­πιθ. 34 (Συ­μπλ. Α): Α35 (1993)
26. Janis, R.A., Silver, P.J., Triggle, D.J.: Drug ac­tion and cellular calcium regulation. Adv. Drug. Res. 16: 309 (1987)
27. Godfraind, T., Miller, R., Wibo, M.: Calcium an­tagonism and calcium entry blockade. Pharmacol. Rev. 38: 321 (1986)
28. Janis, R.A., Triggle, D..J: Drugs acting on cal­cium channels. In: Calcium Channels (L. Hurwitz, ed.). CRC Press, 1991
29. Fleckestein, A.: Calcium Antagonism in Heart and Smooth Muscle. Wiley, New York, 1983
30. Boeynaems JM, Pearson JD: P2purinoceptors on vascular endothelial cells. TIPS 1990 11: 64 (1990)
31. Schmitz, G., Robemek, H., Beuck, M., et al.: Ca2+antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanism. Arteriosclerosis 8: 46 (1988)
32. Yang, Z., Arnet, U., von Segesser, L., Sieben­mann, R., Turina, M., Luscher, T.: Different effects of angiotensin-converting enzyme inhibition in human arteries and veins. J. Cardiovasc. Pharmacol. 22 (Suppl 5): S22 (1993)
33. Πα­πα­δό­που­λος, Κ., Σα­κα­ντά­μης, Γ.: Μη­χα­νι­σμοί δρά­σης των α­να­στο­λέ­ων του με­τα­τρε­πτι­κού εν­ζύ­μου της αγ­γει­ο­τα­σί­νης (Α­ΜΕ­Α) κα­τά την α­ντι­ϋ­περ­τα­σι­κή θε­ρα­πεί­α. Γα­λη­νός 5: 467 (1988)
34. Πα­πα­δό­που­λος, Κ.: Η α­ντι­θρομ­βω­τι­κή θε­ρα­πεί­α στην Καρ­διο­λο­γί­α. Ια­τρι­κά Χρο­νι­κά 5: 331 (1982)
35. Salachas, A., Papadopoulos, C., Sakadamis, G., Styliadis, J.: The effect of Ω-3 fatty acids on the ex­ercise tolerance in patients with coronary artery dis­ease. Επιστημονική Επετηρίδα Ιατρικής Σχολής Θεσσαλονίκης (υπό δημοσίευση)
36. Papadopoulos, C..L., Kanonidis, I., Kotridis, I., Papayannis, S., Savatis, S., Gitsios, C., Sakadamis, G.: The effect of trimetazidine (a free radical scav­enger) on reperfusion arrhythmias in acute myocar­dial infarction. Επιστημονική Επετηρίδα Ιατρικής Σχολής Θεσσαλονίκης (υπό δημοσίευση)
37. Πα­πα­δό­που­λος, Κ., Πα­πα­γιάν­νης, Ι.: Α­ντι­θρομ­βω­τι­κά φάρ­μα­κα. Ε­πιθ. Κλιν. Φαρ­μα­κολ. Φαρ­μα­κο­κιν. 9: 45-47 (1991)